Timing the Market: Selling Your Healthcare Practice in 2025
By: Carlos Arce If you were considering selling your medical practice last year but held back, 2025 presents a renewed opportunity to take that step. Market dynamics, buyer demand, and
NEWS FROM US
Expert Commentary
Use our blog to stay informed, engage with legal experts, and ensure your practice thrives within the complex landscape of healthcare law. Search with keywords such as “HIPAA compliance” or “Anti-Kickback Law” – we cover it all with the expertise and precision you need to help you stay compliant and run your business more efficiently.
2025 Outlook: Where the Dollars are flowing for Healthcare Deals
By: Carlos Arce The healthcare investment landscape is heating up, and 2025 is shaping up to be a year of dynamic opportunities. For investors and healthcare providers, understanding the key
Healthcare Marketing Update for Sellers of Weight Loss Medications
By Jeff Cohen The world of healthcare marketing is evolving, particularly in the realm of GLP1s. With skyrocketing demand for treatments like semaglutide-based Ozempic and Wegovy, and Eli Lilly’s tirzepatide-based
Licensed for Care, not Commerce: Ethical Excellence in Healthcare
By: Jeff Cohen A physician recently shared a scenario that highlights an issue many healthcare professionals face today—compartmentalizing professional responsibilities. The doctor works with a platform focusing on GLP-1 receptor
AHCA Exemptions in Florida: Key Issues for Healthcare Providers
By: Carlos Arce Navigating Florida’s healthcare licensure requirements can be complex, especially for providers seeking clarity on exemptions under the Agency for Health Care Administration (AHCA). If you’re a physician
IVe Got Your Legal Back: A Guide to the IV Hydration Business
Credit: Adam Lusthaus Starting an IV Hydration Business: Overlooked Items That Can Sink Your ShipAs an attorney specializing in healthcare law, I often see entrepreneurs excited to launch IV hydration
The Fine Print of Family Ties in Healthcare Compliance
By: Carlos Arce The Healthcare Clinic Act offers several exceptions to the general expectation that healthcare clinics are owned by physicians. One of these exceptions allows non-physician ownership in specific
DEA’s New Telemedicine Rules Aim to Expand Access and Improve Patient Safety
By Jeff Cohen The rise of telemedicine during the COVID-19 pandemic revolutionized how patients access healthcare. To build upon those temporary measures and create structured long-term solutions, the DEA has
What Should Peptide Manufacturers Do if They Receive an FDA Warning Letter?
By: Jeff Cohen Receiving a warning letter from the FDA requires immediate and calculated action to avoid escalation to more severe enforcement measures, such as product seizure, injunctions, or even
Understanding FDA Warning Letters for Peptide Manufacturers
By: Jeff Cohen Operating in the peptide industry comes with a critical responsibility to meet the standards set by regulatory authorities, particularly the U.S. Food and Drug Administration (FDA). A
